Automated insulin system for diabetes in simulated hospital
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial is testing a closed-loop system that automatically adjusts insulin delivery to keep blood sugar in a healthy range, in a simulated hospital setting. If you have type 1 or type 2 diabetes and use insulin, this could help you manage your glucose more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with type 1 or type 2 diabetes for at least 3 months.
- You use insulin injections at home to control your blood sugar.
- Your most recent A1C (a blood test that shows average blood sugar over 3 months) is between 7.0% and 10.0%.
- Your hemoglobin (a protein in red blood cells) is within a certain range, and your weight is between 40 and 150 kg.
- You do not have serious heart, liver, or kidney disease, a history of seizures or stroke, or uncontrolled infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This study compares two ways to manage blood sugar in the hospital for people with type 2 diabetes: an automated insulin delivery system (a pump worn on the body with a continuous glucose monitor) versus the usual daily insulin injections. The goal is to see if the automated system keeps blood sugar in a safer range during an acute illness.
This trial tests a 'closed-loop' system that automatically adjusts insulin delivery for people with type 2 diabetes. If you already use insulin and certain diabetes medications, this study could help see if a smart insulin pump improves blood sugar control.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.